Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target raised by Cantor Fitzgerald from $11.00 to $16.00 in a research report report published on Thursday, The Fly reports. Other research analysts have also issued reports about the company. Citigroup dropped their price target on Longboard Pharmaceuticals from $24.00 to $17.00 and set a buy […]
Xequel Bio has selected Societal CDMO to support the ongoing clinical development of a patented new chemical entity based on its aCT1 (alpha-Connexin carboxyl-Terminal 1 peptide) platform.
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target increased by Cantor Fitzgerald from $11.00 to $16.00 in a report published on Thursday, The Fly reports. A number of other research firms have also weighed in on LBPH. HC Wainwright reiterated a buy rating and issued a $25.00 price objective on shares of Longboard […]
Operator: Good day, ladies and gentlemen, and welcome to the Societal CDMO First Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Research analysts at B. Riley issued their Q2 2023 earnings per share (EPS) estimates for Longboard Pharmaceuticals in a report issued on Wednesday, May 10th. B. Riley analyst K. Patel anticipates that the company will post earnings per share of ($0.55) for the quarter. B. Riley currently […]